Organogenesis rises as Q3 revenue beats estimates

Organogenesis Holdings

07/11/2025 17:16

** Shares of regenative medicine maker Organogenesis ORGO.O surge 54% to $6

** Co late on Thursday reported Q3 product revenue of $150.5 million, beating analysts' estimate of $134.10 million, according to LSEG data

** Co posted adjusted EBITDA of $30.1 million vs an estimate of $17.4 million

** As of last close, ORGO stock was up 85.9% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))